FDA Import Refusal 799-3942853-9/11/1 — The Exchange Tower
The FDA refused shipment 799-3942853-9/11/1 from The Exchange Tower (Canada) on Nov 22, 2024. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 22, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCK74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75